S3-E44.3 - Anticipating the Aftermath: Previewing Outcomes of Paris NASH
Send us Fan Mail The group concludes the preview of the upcoming Paris NASH conference after taking a thorough look at the diversity of topics in Session 5. Roger Green poses the closing question: Wha...
10 Syys 202213min
S3-E44.2 - Highlights from Paris NASH and an Integrated Multi-Specialty Approach
Send us Fan Mail This conversation picks up focusing on the program’s opening session: Epidemiology and Public Health. Roger, Louise and Jörn begin to unpack the field of NASH in terms of adopting a h...
10 Syys 202213min
S3-E44.1 - Paris NASH Meeting Preview: Program Highlights on Metabolics
Send us Fan Mail In this conversation, Roger Green, Louise Campbell, Jörn Schattenberg and Rachel Zayas share their particular interests in what’s to come from the 6 sessions hosted at this year’s Par...
10 Syys 202214min
S3-E44 - A Preview of Paris NASH and NAFLD Summit 2022
Send us Fan Mail The 8th Paris NASH Meeting takes place on September 8th & 9th, where key opinion leaders from both sides of the Atlantic come together to present pivotal learnings and host exciting d...
8 Syys 20221h 3min
From the Vault: Future NASH Drug Development: More Diverse Trial Populations and More Study of Combination NASH Drugs
Send us Fan Mail This conversation from The Vault - Season 3, Episode 25.3 is part of a broader overview of NASH drug development in 2022, led by Stephen Harrison and Jörn Schattenberg. It starts with...
4 Syys 20221h 36min
S3-E43.5 - The Future of Combination Agents in NASH Therapy
Send us Fan Mail The group investigates potential for different combination packages, beginning with Roger’s suggestion for an oral semaglutide. Naim notes that there are other combination trials in t...
4 Syys 202210min
S3-E43.4 - Optimizing Combination Agents
Send us Fan Mail This conversation begins with a broader look at the strategies behind developing combination agents and the role these combination therapies will play in what Mazen Noureddin describe...
4 Syys 202212min
S3-E43.3 - Science Partnerships and NASH Trials
Send us Fan Mail The discussion shifts to the challenges behind collaborating in a field that, as Naim puts it, “no one has figured out what to do with.” Mazen calls on the “larger companies” to work ...
3 Syys 202213min
